Please enter your username and password below, if you are not yet a member of Oncology Central remember you can register for free.
Already have an account? Login here
Categories // Subject Area // News
A study led by the Spanish National Cancer Research Centre (CNIO; Madrid, Spain) in collaboration with Weill Cornell Medicine Center (NY, USA) and Pfizer Inc. (NY, USA) has proposed a potential strategy to prevent the development of chemotherapy resistance in pancreatic cancer patients.
It's completely free
Written ByCaitlin Killen, Future Science Group
Updated 10 March, 2020